ArticleCureus2025
Uninsured Patients Under Dialysis in Greece: A Case-Control Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTreating uninsured patients with end-stage renal disease (ESRD) undergoing dialysis is a challenge for every country. Greece has adopted a three-week scheduled outpatient over emergency dialysis for uninsured patients with ESRD from the pandemic until now. In this observational study, we describe the experience of treating uninsured ESRD patients in a private dialysis unit in Greece.
methodsA total of 50 patients who underwent dialysis at Frontis Dialysis Center, Piraeus, Greece, were analyzed. Clinical and laboratory data were prospectively collected from 25 uninsured consecutive patients and compared with 25 age- and sex-matched insured dialysis patients who served as controls.
resultsThe uninsured population was treated with three-week scheduled dialysis session. The mean age of the study population was 44.4 years (SD=13.5), and 68% were male. At presentation, 60% of uninsured patients were treated with hemodialysis via central venous catheter, and hemodiafiltration dialysis was applied only in 20% of them (p-value <0.001). Initially, the median hemoglobin (9.8 g/dL (min-max: 8-12.1) versus 11 g/dL (min-max: 9-14), p-value=0.04) and albumin (3.6 g/dL (min-max: 2-4) versus 4 g/dL (min-max: 3.3-4.6), p-value=0.008) levels were significantly lower, while the median ferritin (518 ng/mL (min-max: 104-2,149) versus 208 ng/mL (min-max: 16-1,333), p-value <0.001) and parathormone (iPTH) levels (799 pg/dL (min-max: 168-2,811) versus 410 pg/dL (min-max: 13-923), p-value <0.001) were significantly higher for the uninsured patients. After three months, uninsured patients improved their anemia and nutritional status, but ferritin and iPTH levels were still significantly higher. At the end of follow-up, there were no differences between the two groups. Rates of hospitalization (40% versus 32%, p-value=0.5) and infections (24% versus 12%, p-value=0.2) did not differ between groups. During the study, there was only one cardiovascular event in the control group, and none in the uninsured group of patients. None of the patients died during the study.
conclusionsUninsured patients who received three-week scheduled dialysis sessions improved all their laboratory values and had zero mortality. Healthcare policy has to take into account that scheduled dialysis sessions result in favorable outcome for uninsured patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.